Chronic Disease Anemia
Understand Anemia of Chronic Disease (ACD), also known as Anemia of Inflammation. This meta description provides information on the diagnosis, clinical documentation, and medical coding (ICD-10-CM) for healthcare professionals. Learn about the connection between chronic disease and anemia, including diagnostic criteria and treatment considerations. Explore resources for accurate medical coding and improved clinical documentation practices related to Anemia of Chronic Disease.
Anemia caused by chronic inflammation, infection, or malignancy, impairing iron utilization.
Fatigue, weakness, pallor, shortness of breath, reduced exercise capacity.
Rheumatoid arthritis, chronic kidney disease, inflammatory bowel disease, infections, cancer.
ICD-10 Code Families
Complete code families applicable to D63.8
When to use each related code
| Description | When to use |
|---|---|
| Anemia due to chronic inflammation. | Use for anemia associated with chronic conditions like infections, autoimmune diseases, or cancer. |
| Iron deficiency anemia due to low iron levels. | Code when anemia is caused by inadequate iron intake, absorption, or increased loss. Check ferritin levels. |
| Anemia caused by vitamin B12 deficiency. | Use when anemia is due to low B12. Consider pernicious anemia or dietary deficiency as causes. |
Best-practice checklist
- ✓Document underlying chronic disease (e.g., rheumatoid arthritis, CKD)
- ✓Specify anemia type (normocytic, normochromic initially)
- ✓Hb/Hct, RBC indices, iron studies, ferritin levels
- ✓Exclude other anemia causes (iron, B12, folate deficiency)
- ✓Document treatment plan and response to therapy
Common pitfalls to avoid
Coding C chronic disease anemia without specifying the underlying chronic condition leads to inaccurate severity and reimbursement.
Misdiagnosis of iron deficiency anemia instead of anemia of chronic disease can result in inappropriate treatment and coding errors.
Insufficient documentation of the chronic disease causing the anemia may lead to coding denials and compliance issues in medical records.
Best-practice tips
- 01Document underlying chronic disease (ICD-10 codes) for ACD diagnosis (D63.8).
- 02Specify type of chronic disease for accurate coding and reimbursement.
- 03Evaluate iron studies, including ferritin and transferrin saturation.
- 04Consider EPO stimulating agents if anemia is severe and EPO is low.
- 05Regular monitoring of hemoglobin and hematocrit for CDI compliance.
Step-by-step checklist
- 1
Verify underlying chronic disease diagnosis (ICD-10 codes)
- 2
Confirm Hb/Hct, MCV, ferritin, iron levels documented
- 3
Assess for signs/symptoms of anemia (fatigue, pallor)
- 4
Rule out other anemia causes (iron, B12, folate deficiency)
Ready-to-paste narrative
Patient presents with symptoms suggestive of anemia of chronic disease (ACD), also known as anemia of inflammation. Presenting complaints include fatigue, weakness, and decreased exercise tolerance. On physical examination, the patient exhibited pallor. Laboratory findings reveal a normocytic or slightly microcytic anemia with a low hemoglobin and hematocrit. Serum iron is low, total iron-binding capacity (TIBC) is low or normal, and ferritin is normal or elevated. These findings are consistent with the diagnostic criteria for anemia of chronic inflammation. The underlying chronic disease is documented as [Specific underlying disease, e.g., rheumatoid arthritis, chronic kidney disease, inflammatory bowel disease]. Differential diagnoses considered included iron deficiency anemia, thalassemia, and sideroblastic anemia. These were ruled out based on the patient's laboratory results and clinical presentation. Treatment plan includes addressing the underlying chronic disease. Iron supplementation is not routinely recommended due to the pathophysiology of ACD and potential risks. Patient education provided regarding the relationship between anemia and the underlying chronic disease, as well as the importance of ongoing monitoring of hemoglobin, hematocrit, and iron studies. ICD-10 code [Appropriate ICD-10 code, e.g., D63.8, Other specified anemias] applied for medical billing and coding purposes. Follow-up scheduled to monitor response to treatment and disease management.
Common questions and answers
How can I differentiate Anemia of Chronic Disease from Iron Deficiency Anemia in a patient with a chronic inflammatory condition like rheumatoid arthritis?+
Differentiating Anemia of Chronic Disease (ACD) from Iron Deficiency Anemia (IDA) in patients with chronic inflammation, such as rheumatoid arthritis, can be challenging due to overlapping symptoms. Key distinguishing features include: serum ferritin levels (usually normal or elevated in ACD, low in IDA), transferrin saturation (low in both but typically lower in IDA), total iron-binding capacity (low in ACD, high in IDA), and soluble transferrin receptor (normal or slightly elevated in ACD, significantly elevated in IDA). Furthermore, hepcidin, a key regulator of iron homeostasis, is elevated in ACD due to inflammation, contributing to reduced iron absorption and release from stores. Bone marrow iron stores are normal or increased in ACD but absent in IDA. Consider implementing a comprehensive assessment including these markers to accurately differentiate ACD from IDA. Explore how inflammatory markers like C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) can aid in diagnosis. Accurate diagnosis is crucial for appropriate management.
What are the best evidence-based treatment strategies for managing Anemia of Inflammation secondary to chronic kidney disease?+
Managing Anemia of Inflammation (AI) in patients with chronic kidney disease (CKD) requires a multi-faceted approach. The primary focus should be on addressing the underlying chronic disease. While iron supplementation may seem intuitive, it's often ineffective and potentially harmful in ACD due to impaired iron utilization. Erythropoiesis-stimulating agents (ESAs) can be considered, particularly for patients with hemoglobin levels below 10 g/dL, however, their use requires careful monitoring for potential adverse effects, including thromboembolic events and hypertension. Explore how optimizing iron status through intravenous iron administration can enhance ESA responsiveness in select CKD patients. Learn more about the latest guidelines for ESA usage and iron management in CKD-related anemia, considering the risks and benefits for individual patients.
What are the common pitfalls to avoid when diagnosing and managing Anemia of Chronic Disease in a patient with underlying malignancy?+
Diagnosing and managing Anemia of Chronic Disease (ACD) in patients with underlying malignancy can be complex. One common pitfall is attributing the anemia solely to the malignancy or chemotherapy without considering the contribution of ACD. Another pitfall is prematurely initiating iron supplementation, which can exacerbate inflammation and is generally ineffective in ACD. Overreliance on red blood cell transfusions without addressing the underlying inflammation can lead to iron overload. It's crucial to conduct a thorough evaluation, including iron studies, inflammatory markers, and a careful assessment of the underlying malignancy and its treatment. Consider implementing a stepwise approach to anemia management, starting with optimizing treatment of the underlying malignancy and addressing any coexisting nutritional deficiencies. Learn more about the role of newer agents targeting specific inflammatory pathways in managing ACD in cancer patients.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.